Qijue Lu

639 total citations
22 papers, 451 citations indexed

About

Qijue Lu is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Qijue Lu has authored 22 papers receiving a total of 451 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 6 papers in Oncology and 6 papers in Cancer Research. Recurrent topics in Qijue Lu's work include Cancer-related gene regulation (5 papers), Epigenetics and DNA Methylation (4 papers) and MicroRNA in disease regulation (4 papers). Qijue Lu is often cited by papers focused on Cancer-related gene regulation (5 papers), Epigenetics and DNA Methylation (4 papers) and MicroRNA in disease regulation (4 papers). Qijue Lu collaborates with scholars based in China. Qijue Lu's co-authors include Hezhong Chen, Chunguang Li, Yue Zhao, Xiang Fei, Ji Zhu, Chaojing Lu, Chun Guang Li, Xinyu Wang, Yang Yuan and Shengdong Huang and has published in prestigious journals such as Cell Death and Disease, Journal of Experimental & Clinical Cancer Research and International Journal of Biological Sciences.

In The Last Decade

Qijue Lu

21 papers receiving 446 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qijue Lu China 11 342 226 82 69 62 22 451
Jin‐Ling Duan China 13 265 0.8× 139 0.6× 93 1.1× 105 1.5× 45 0.7× 29 407
Meng Pu China 10 465 1.4× 386 1.7× 45 0.5× 63 0.9× 52 0.8× 19 582
Dong‐Qiu Dai China 16 438 1.3× 391 1.7× 83 1.0× 43 0.6× 35 0.6× 33 548
Dimitris Delakas Greece 9 269 0.8× 197 0.9× 90 1.1× 48 0.7× 87 1.4× 9 391
Shan Liu China 12 252 0.7× 239 1.1× 49 0.6× 66 1.0× 28 0.5× 34 376
Satoru Inoguchi Japan 10 461 1.3× 410 1.8× 68 0.8× 45 0.7× 55 0.9× 21 567
Wensong Liu China 9 225 0.7× 206 0.9× 44 0.5× 106 1.5× 56 0.9× 18 357
Xiaping Wang China 9 164 0.5× 183 0.8× 59 0.7× 102 1.5× 46 0.7× 20 330
Jinsei Miyoshi Japan 8 312 0.9× 196 0.9× 46 0.6× 76 1.1× 75 1.2× 17 434
Bingqiu Xiu China 9 282 0.8× 264 1.2× 64 0.8× 94 1.4× 122 2.0× 38 501

Countries citing papers authored by Qijue Lu

Since Specialization
Citations

This map shows the geographic impact of Qijue Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qijue Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qijue Lu more than expected).

Fields of papers citing papers by Qijue Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qijue Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qijue Lu. The network helps show where Qijue Lu may publish in the future.

Co-authorship network of co-authors of Qijue Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Qijue Lu. A scholar is included among the top collaborators of Qijue Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qijue Lu. Qijue Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lu, Qijue, Yichen Dong, Yue Zhao, et al.. (2025). Survival benefits in non-small cell lung cancer during the immune checkpoint inhibitor era: integrating lymph node burden for prognostic precision. Translational Lung Cancer Research. 14(9). 3363–3377.
2.
Li, Chun Guang, Qijue Lu, Yang Yang, et al.. (2023). Oncolytic adenovirus-mediated dual knockdown of survivin and OCT4 improves therapeutic efficacy in esophageal cancer. Annals of Translational Medicine. 11(5). 193–193. 5 indexed citations
3.
Lu, Qijue, et al.. (2021). Elevated tumor markers in a benign lung disease. Journal of Cardiothoracic Surgery. 16(1). 308–308. 6 indexed citations
4.
Zhu, Ji, Qijue Lu, Bin Li, et al.. (2021). Potential of the cell‑free blood‑based biomarker uroplakin 2 RNA to detect recurrence after surgical resection of lung adenocarcinoma. Oncology Letters. 22(1). 520–520. 3 indexed citations
6.
Wang, Xinyu, Qijue Lu, Fei Xiang, et al.. (2020). <p>Expression and Prognostic Value of Id-4 in Patients with Esophageal Squamous Cell Carcinoma</p>. OncoTargets and Therapy. Volume 13. 1225–1234. 4 indexed citations
7.
Wang, Xinyu, Yue Zhao, Xiang Fei, et al.. (2020). LEF1/Id3/HRAS axis promotes the tumorigenesis and progression of esophageal squamous cell carcinoma. International Journal of Biological Sciences. 16(13). 2392–2404. 6 indexed citations
8.
Wang, Xinyu, et al.. (2020). The influence of thoracic duct ligation on long-term survival of patients with esophageal cancer: a propensity score-matched analysis. Journal of Thoracic Disease. 12(10). 5532–5541. 9 indexed citations
9.
Xu, Li, Ye Ma, Hua Zhang, et al.. (2020). HMGA2 regulates circular RNA ASPH to promote tumor growth in lung adenocarcinoma. Cell Death and Disease. 11(7). 593–593. 21 indexed citations
10.
Lu, Qijue, Xinyu Wang, Ji Zhu, et al.. (2020). <p>Hypoxic Tumor-Derived Exosomal Circ0048117 Facilitates M2 Macrophage Polarization Acting as miR-140 Sponge in Esophageal Squamous Cell Carcinoma</p>. OncoTargets and Therapy. Volume 13. 11883–11897. 71 indexed citations
11.
Wang, Xinyu, Bowen Shi, Yue Zhao, et al.. (2020). HKDC1 promotes the tumorigenesis and glycolysis in lung adenocarcinoma via regulating AMPK/mTOR signaling pathway. Cancer Cell International. 20(1). 450–450. 48 indexed citations
12.
Zhao, Yue, Qijue Lu, Chunguang Li, et al.. (2019). PRMT1 regulates the tumour-initiating properties of esophageal squamous cell carcinoma through histone H4 arginine methylation coupled with transcriptional activation. Cell Death and Disease. 10(5). 359–359. 62 indexed citations
13.
Zhao, Yue, Ji Zhu, Bowen Shi, et al.. (2019). The transcription factor LEF1 promotes tumorigenicity and activates the TGF-β signaling pathway in esophageal squamous cell carcinoma. Journal of Experimental & Clinical Cancer Research. 38(1). 304–304. 37 indexed citations
14.
Li, Xin, Qijue Lu, Chunguang Li, et al.. (2019). Differentiated super-enhancers in lung cancer cells. Science China Life Sciences. 62(9). 1218–1228. 3 indexed citations
15.
Lu, Qijue, et al.. (2018). Epidermal growth factor receptor mutation accelerates radiographic progression in lung adenocarcinoma presented as a solitary ground-glass opacity. Journal of Thoracic Disease. 10(11). 6030–6039. 6 indexed citations
17.
Xu, Li, Bin Du, Qijue Lu, et al.. (2018). miR‐541 suppresses proliferation and invasion of squamous cell lung carcinoma cell lines via directly targeting high‐mobility group AT‐hook 2. Cancer Medicine. 7(6). 2581–2591. 21 indexed citations
18.
Zhao, An, Fan Qiao, Qijue Lu, et al.. (2017). Interleukin-6 downregulated vascular smooth muscle cell contractile proteins via ATG4B-mediated autophagy in thoracic aortic dissection. Heart and Vessels. 32(12). 1523–1535. 30 indexed citations
19.
Lu, Qijue, Li Xu, Chunguang Li, et al.. (2016). miR-214 inhibits invasion and migration via downregulating GALNT7 in esophageal squamous cell cancer. Tumor Biology. 37(11). 14605–14614. 32 indexed citations
20.
Xu, Li, Weilin Liao, Qijue Lu, et al.. (2016). ANG Promotes Proliferation and Invasion of the Cell of Lung Squamous Carcinoma by Directly Up-Regulating HMGA2. Journal of Cancer. 7(7). 862–871. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026